ArticleNature communications2021

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma.

Daniel Schäfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.